Reporter
VUMC Recognized by Forbes as One of America’s Best In-State Employers
Aug. 24, 2021—Forbes has recognized Vanderbilt University Medical Center as one of America’s Best-In-State Employers for 2021 according to the publication’s annual award list published on Forbes.com.
New Clinician Spotlight: Neil Price
Aug. 24, 2021—Neil Price, MD, assistant professor of Clinical Medicine, joined Vanderbilt University Medical Center recently and specializes in gastroenterology.
Autoimmunity advance
Aug. 24, 2021—Vanderbilt researchers have developed a high-throughput screening method to identify and characterize antigen-specific B cells — potential biomarkers for autoimmune disease and targets for new treatments.
Estrogen, depression and menopause
Aug. 23, 2021—A shift in emotional processing may help women adapt to lower estrogen after menopause —unless they have a history of major depressive disorder, Vanderbilt researchers have found.
‘DNA’ podcast Season 2 explores COVID, science and trust in communities
Aug. 23, 2021—Listen to Episode 1, Blueprint for a Pandemic-Ready Society, and subscribe on your favorite platform. The first episode of the second season of Vanderbilt University Medical Center’s original podcast series, Vanderbilt Health DNA: Discoveries in Action, tackles bold questions and issues pushed to the surface by COVID-19. This season, the award-winning 10-episode series delves into...
COVID-19 antibody ‘cocktail’ discovered at VUMC protects chronically ill: study
Aug. 20, 2021—A monoclonal antibody cocktail against the COVID-19 virus discovered at Vanderbilt University Medical Center and developed by AstraZeneca reduced the risk of symptoms in a study of immunocompromised and chronically ill adults later exposed to the virus by 77%, the company announced today.
Potential protection from atherosclerosis
Aug. 19, 2021—Vanderbilt researchers have discovered a potential way to reduce atherosclerosis: blocking the modification of an HDL-associated enzyme by reactive molecules called isolevuglandins.
Expression atlas for cell regulators
Aug. 19, 2021—Vanderbilt researchers report a comprehensive tissue-specific atlas of protein and mRNA expression for p63 and p73, members of the p53 family signaling network that is the most frequent target of mutations in human cancers.
Team isolates antibodies that target alphaviruses
Aug. 19, 2021—A multi-institutional team led by researchers at Vanderbilt University Medical Center has isolated monoclonal antibodies that in laboratory and animal studies prevented infection by alphaviruses, including the often-lethal Eastern equine encephalitis virus (EEEV).
Park named to new role as deputy director of Vanderbilt-Ingram Cancer Center
Aug. 19, 2021—Ben Ho Park, MD, PhD, Cornelius Abernathy Professor of Medicine, has been named deputy director of Vanderbilt-Ingram Cancer Center (VICC).
Transplant Pharmacy’s Osman donates kidney to former boss
Aug. 19, 2021—Over the last two years at Vanderbilt University Medical Center, Transplant Pharmacy technician Sarah Osman, CPhT, has become very familiar with the process of organ transplantation.
Children, firearms mixing more during pandemic
Aug. 19, 2021—Researchers at Monroe Carell Jr. Children’s Hospital at Vanderbilt discovered an alarming finding during the height of the pandemic — a marked increase in firearm encounters among children.
